Kaplan–Meier analysis further indicated that high JMJD6 levels correlated with worse overall survival (OS) and progression‐free survival for patients from the TCGA‐KIRC cohort and Ruijin‐RCC dataset (Figures 2H and 2I). The gene discussed is JMJD6; the disease is renal cell carcinoma.